Will IRIDEX stock go up?

According to Danelfin AI, IRIDEX has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (48.94%) is -1.88% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for IRIDEX stock?

The IRIDEX target price is $2.9 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold IRIDEX stock right now?

IRIDEX has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (48.94%) is -1.88% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether IRIDEX stock is a good buy .

Is IRIDEX undervalued right now?

Based on analysts, the average price target upside for IRIDEX is +143.36% (1Y). According to Danelfin AI, IRIDEX has today an AI Score of 4/10 (Hold Rating).

What was the price range of IRIDEX stock over the past 12 months?

The IRIDEX stock price range over the past 12 months has been $0.88 - $1.56.

What is going on with IRIDEX stock in the last 3 months?

The IRIDEX stock performance in the last quarter has been +17.82%.

Does IRIDEX offer dividend payments?

No, IRIDEX does not currently pay dividends.

What is the current market capitalization of IRIDEX?

IRIDEX's market cap is $20.37M, as of 2026-07-02 08:00.

When is the next IRIX earnings report date?

IRIX will publish its next earnings report on 2026-05-19.

IRIDEX Corp (IRIX) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

IRIX AI-Powered Stock Analysis

AI Score Explanation

AI Score

Hold

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, IRIDEX Corp today receives an AI Score of 4/10, which translates to a Hold rating. The stock has a 49% probability of outperforming the market in the next 3 months, which is 2% lower than the average probability of any stock (51%). The top positive contributors include the Technicals Impact (Long Tail) (+3.06%), Fundamentals Impact (Long Tail) (+2.96%), and ATR (90d Volatility) (+2.28%), with the latter in the bottom 10% indicating low volatility. Conversely, the top detractors are the Industry (GICS) (-7.29%), Fear & Greed Index (CNN) (-2.67%), and Chart Pattern (504d) (-2.48%), reflecting headwinds from sector classification, market sentiment, and technical patterns. Notable data points include a Short Float (%) of 18% in the bottom 10%, suggesting low bearish sentiment, and an Alpha 1Y of 14.2% in the top 30%, indicating strong risk-adjusted returns. However, the Operating Profit Margin is -274.6% in the bottom 40%, highlighting severe profitability challenges. The Fear & Greed Index at 31 signals fear, while the Earnings in Next 15 Days flag adds uncertainty. Overall, the stock’s probability is weighed down by industry and sentiment factors, but supported by technical and fundamental long-tail signals, resulting in a balanced Hold rating.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Momentum+4.95%
Direction and strength of recent price movements
Volatility+4.66%
How much the stock price tends to fluctuate

Sentiment-8.52%
How analysts and the market view the stock
Size & Liquidity-1.58%
Company size and trading liquidity
Profitability-1.39%
Profitability and operating efficiency metrics
Valuation0.00%
How the stock is priced relative to its fundamentals

IRIX probability advantage of beating the market (3M):

-1.88%

AI Score

Hold

IRIDEX (IRIX) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of -1.88% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of IRIX (48.94%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
IRIX probability advantage of beating the market (3M)-1.88%
IRIX probability of beating the market (3M)48.94%

IRIX probability advantage of beating the market (3M): -1.88%

The AI-powered overall analysis of IRIDEX (IRIX) is based on the 26 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of IRIX:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Health Care Equipment & Supplies	N/A	-7.29%
Technical	Technicals Impact (Long Tail)	-	N/A	+3.06%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+2.96%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-2.67%
Technical	Chart Pattern (504d)	figure_56	N/A	-2.48%
Technical	ATR (90d Volatility)	0.06	N/A	+2.28%
Fundamental	Net Property, Plant & Equipment (Net PP&E)	0.14	N/A	-1.73%
Technical	Chart Pattern (90d)	figure_19	N/A	+1.72%
Technical	ATR (14d Volatility)	0.05	N/A	+1.71%
Technical	Chart Pattern (60d)	figure_109	N/A	+1.58%
Fundamental	Upgrade to unlock			-1.58%
Technical	Upgrade to unlock			+1.39%
Fundamental	Upgrade to unlock			-1.39%
Sentiment	Upgrade to unlock			-1.34%
Sentiment	Upgrade to unlock			+1.27%

Rest of Alpha Signals: +0.61%

IRIX probability advantage of beating the market (3M)Total:-1.88%
IRIX AI Score

Significant changes Vs previous day

IRIX Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$1.19
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

IRIX Proven Hold Signal & Price Forecast

This is the price chart for IRIX from January 2, 2026 until today. The chart indicates, in yellow, the 71 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

IRIX Average Past Performance & Win Rate

Three months after its 1398 Hold signals since July 2026, IRIX had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

1398 Past IRIX Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+12.37%
Average Alpha				-3.12%
Win Rate (% Positive Perf.)				28.72%
% Positive Alpha				17.78%

IRIX Frequently Asked Questions

Will IRIDEX stock go up?
According to Danelfin AI, IRIDEX has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (48.94%) is -1.88% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for IRIDEX stock?
Is it a good time to buy, sell, or hold IRIDEX stock right now?
Is IRIDEX undervalued right now?
What was the price range of IRIDEX stock over the past 12 months?
What is going on with IRIDEX stock in the last 3 months?
Does IRIDEX offer dividend payments?
What is the current market capitalization of IRIDEX?
When is the next IRIX earnings report date?

IRIDEX Corp Company Profile

IRIDEX Corporation operates as a progressive ophthalmic medical technology entity, delivering laser systems based on therapeutic principles, paired with delivery mechanisms and supplementary instrumentation dedicated to the treatment of serious ocular conditions. This is performed within the realm of ophthalmology, a specialised branch of medicine focused on eye care.

The corporation's product lineup features an array of laser consoles. The Cyclo G6 model is specifically designed for addressing glaucoma, while the IQ 532 and IQ 577 systems are engineered for remedying retinal disorders. The OcuLight series, encompassing the TX, SL, SLx, GL and GLx models of laser photocoagulation systems, take aim at combatting proliferative diabetic retinopathy alongside macular holes, retinal tears and detachments.

IRIDEX also dispenses supplementary delivery devices required by practitioners. These include the multifaceted TxCell scanning laser delivery instrument enables multi-spot pattern exploration by physicians. Additionally, the provision of slit lamp adapters integrates seamlessly with standard slit lamps during diagnostic procedures and treatments. For peripheral retinal disorder treatments, there's a dedicated laser indirect ophthalmoscope.

Further expanding its portfolio are specific products such as MicroPulse P3 Probe – used alongside Cyclo G6 for performing transscleral MicroPulse laser exhibitions; an innovative G-Probe intended for tackling unregulated glaucoma; as well as a range labelled EndoProbe intended for vitrectomy procedures.

Serving a broad array of clientele ranging from individual ophthalmologists to veterinary practices, teaching hospitals to research institutions, IRIDEX ensures its solutions reach through both direct sales force regionally and independent distributors internationally.

This thriving corporation started its journey originally under 'IRIS Medical Instruments Inc.' before rebranding to become IRIDEX Corporation in November 1995. Formally incorporated in 1989 with headquarters stationed in Mountain View, California, IRIDEX continues its mission to advance in the field of ophthalmic technology.

Sector:Health Care
Country:United States
Industry:
Address:1212 Terra Bella Ave, Mountain View
Employees:93
Website:iridex.com

Pros

Aging global demographics driving ophthalmology demand

Recurring revenue from proprietary disposable probes

High switching costs for trained medical professionals

Regulatory barriers to entry in medical device market

Specialized niche in non-invasive laser eye treatments

Cons

Dependence on physician adoption of new laser therapies

Reimbursement policy changes impacting procedure volumes

Competition from alternative treatment modalities

Capital intensity of medical device research and development

Long sales cycles for capital equipment purchases

Company	AI Score	Compare
GKOSGlaukos Corp
RXSTRxsight Inc
POCIPrecision Optics Corporation Inc
SGHTSight Sciences Inc
LNSRLENSAR Inc

Company	AI Score	Compare
GKOSGlaukos Corp
RXSTRxsight Inc
POCIPrecision Optics Corporation Inc
SGHTSight Sciences Inc
LNSRLENSAR Inc

IRIX Stock AI Analysis

IRIDEX Corp

IRIX Stock AI Analysis

IRIDEX Corp

IRIX AI-Powered Stock Analysis

AI Score Explanation

AI Score Explanation

Generating AI Score explanation

AI Score Alpha Factors

Alpha Signals: What Drives the AI Score

IRIX probability advantage of beating the market (3M): -1.88%

IRIX Trading Parameters

IRIX Proven Hold Signal & Price Forecast

IRIX Average Past Performance & Win Rate

IRIX Frequently Asked Questions

Will IRIDEX stock go up?

What is the target price for IRIDEX stock?

Is it a good time to buy, sell, or hold IRIDEX stock right now?

Is IRIDEX undervalued right now?

What was the price range of IRIDEX stock over the past 12 months?

What is going on with IRIDEX stock in the last 3 months?

Does IRIDEX offer dividend payments?

What is the current market capitalization of IRIDEX?

When is the next IRIX earnings report date?

IRIDEX Corp Company Profile

Pros

Cons

Pros

Cons

IRIX Company Profile Summary

IRIX Related Investment Themes

IRIX Related Stocks

IRIX Top 10 Industry Stocks

Health Care Equipment & Supplies

IRIX Top 10 Sector Stocks

Health Care

IRIX Stock AI Analysis

IRIDEX Corp

NASDAQ NMS - GLOBAL MARKET

Will IRIDEX stock go up?

What is the target price for IRIDEX stock?

Is it a good time to buy, sell, or hold IRIDEX stock right now?

Is IRIDEX undervalued right now?

What was the price range of IRIDEX stock over the past 12 months?

What is going on with IRIDEX stock in the last 3 months?

Does IRIDEX offer dividend payments?

What is the current market capitalization of IRIDEX?

When is the next IRIX earnings report date?

Pros

Cons

NASDAQ NMS - GLOBAL MARKET

AI Score Explanation

IRIX Proven Hold Signal & Price Forecast